(DIR) Home
        
        
       Marijuana Moment
        
 (HTM) Source
        
       ----------------------------------------------------------------------
        
       With the federal government moving to reschedule marijuana, a
       Democratic congressman has issued a new memo on cannabis reform
       priorities to reflect renewed "optimism for the path ahead"—laying out
       suggestions to advance the issue both in Congress and
       administratively.
        
       Rep. Earl Blumenauer (D-OR), founding co-chair of the Congressional
       Cannabis Caucus, issued the memo on Tuesday—about a week after the
       Justice Department confirmed that it proposed reclassifying marijuana
       under the Controlled Substances Act (CSA).
        
       "Schedule III is not quite what we wanted—marijuana shouldn't be
       scheduled at all—but it is nonetheless a revolutionary step that sends
       a signal about the imperative of ending the failed war on drugs,"
       Blumenauer said, adding that cannabis is "a winning issue."
        
       "It is clear the Biden-Harris Administration is listening to the
       unprecedented public demand for cannabis reform. President Biden has
       been much more engaged on the issue," the memo says. "He pardoned
       thousands of individuals, initiated this long-overdue review of
       scheduling, and opened a new chapter for reform. The Administration
       must move through the regulatory process as quickly as possible to
       reschedule cannabis."
        
       The memo also lays out the key implications of rescheduling, including
       allowing marijuana businesses to take federal tax deductions and
       removing cannabis research barriers. The administrative move also
       represents a critical acknowledgement of the medical value of
       marijuana, it says.
        
       "With the DOJ's announcement, this updated memo reflects my optimism
       for the path ahead and details the work that remains," Blumenauer
       said, referencing an earlier annual document he issued in January.
        
       The congressman's memo emphasizes that while rescheduling represents a
       "significant step toward ending the failed war on drugs, there is
       still significant work ahead for Congress."
        
       To that end, the memo stresses that the "work includes ending the
       criminalization of marijuana." As the Congressional Research Service
       (CRS) said in a report last week, Blumenauer notes that a Schedule III
       reclassification would not legalize marijuana, and certain cannabis-
       related activity would continue to be criminalized under the CSA.
        
       For the remainder of the congressional session, Blumenauer said that
       lawmakers should focus on advancing legislation to federally legalize
       cannabis, free up cannabis industry access to the banking system,
       prevent Justice Department interference in state markets and allow the
       U.S. Department of Veterans Affairs (VA) to make medical cannabis
       recommendations to patients.
        
       The memo also makes recommendations for further administrative action,
       including expanding pardons and commutations for people with federal
       marijuana convictions, reissuing "improved" guidance on enforcement
       priorities, updating truck driver THC impairment testing, ending the
       practice of evicting people from federally subsidized housing over
       cannabis and more.
        
       "Throughout the executive branch, the Biden-Harris Administration
       should consider the implications of marijuana prohibition and
       criminalization as they take steps to end discriminatory policies
       across branches and with every power available to them," Blumenauer,
       who is retiring at the end of this Congress, said.
        
       "There is no doubt that critical work remains," he said. "However, we
       should celebrate this historic step forward, which is possible because
       of the tireless work my partners and I have put behind these reforms
       for more than 50 years. I am committed to building on this momentum to
       end the failed cannabis prohibition once and for all."
        
       Last week, the congressman similarly argued that the rescheduling
       decision from DEA will "open the floodgates" for additional
       congressional action such as passage of the bipartisan cannabis
       banking bill.
        
       "It's going to make it much easier to have other items that are queued
       up," the Democratic congressman said. "With this, it's going to be a
       matter of time before we get movement in the Senate—dealing with the
       banking issue, which is long overdue."
        
       "Taking it to Schedule III is, first of all a signal, that people
       recognize that the current scheduling process is completely wrong,
       flawed and unfair," Blumenauer said. "It takes care of a major problem
       that we've faced."
        
       The congressman also reiterated his belief that the Justice Department
       would soon be reissuing marijuana enforcement discretion guidances
       that was rescinded under the Trump administration. He and the former
       DOJ official who authored the original memorandum told Marijuana
       Moment last week that they expect it will be expanded to account for
       societal changes around the issue, as well as the rescheduling push.
        
       Meanwhile, DEA Administrator Anne Milgram told lawmakers on Tuesday
       that it would be "inappropriate" for her to comment on the agency's
       recent marijuana rescheduling determination because the rulemaking
       process is "ongoing."
        
       The head of the Internal Revenue Service (IRS) separately said that
       marijuana industry banking access would make the agency's job easier,
       and officials "shouldn't just sit on our hands" as the federal
       government moves to reschedule cannabis.
        
       **Read Blumenauer's memo on marijuana reform priorities in light of
       the rescheduling decision below:**
        
       > FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next
       > Month
        
       _Photo courtesy of Philip Steffan._
        
       Marijuana Moment is made possible with support from readers. If you
       rely on our cannabis advocacy journalism to stay informed, please
       consider a monthly Patreon pledge.
        
        
        
        
       ______________________________________________________________________
                                                 Served by Flask-Gopher/2.2.1